ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,702,707, issued on Aug. 11, was assigned to The Trustees of the University of Pennsylvania (Philadelphia).

"Modified mRNA vaccines encoding herpes simplex virus glycoproteins and uses thereof" was invented by Harvey Friedman (Merion, Pa.), Drew Weissman (Wynnewood, Pa.), Sita Awasthi (Bala Cynwyd, Pa.) and Gary Cohen (Havertown, Pa.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides compositions for the prevention and treatment of genital herpes, comprising nucleoside modified mRNAs that encode herpes simplex virus (HSV) glycoproteins, including those involved in virus entry and immune evasion, and methods of use thereof."

Th...